ITGR

Integer Holdings Corp Health Care Electromedical & Electrotherapeutic Apparatus Russell 3000
$126.59Close $4.3BMarket cap $63.32 – $126.7552-week range Late-januaryNext report · estimated

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 90 · stronger than 90% of stocks over 12 months
  • Near its high at its 52-week high

Cautions

  • Earnings shrinking EPS −61% year on year

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 29, 2026
Off 12-month high 0%
1wk 0.0% price change
1mo up 0.2% price change
12-month return up 100% market up 11% · its own up 83%
F-score 6 / 9 Mixed
Altman Z 2.92 Moderate risk
P/E 42.3× price / earnings
PEG — P/E / EPS growth
P/B 2.5× price / book
Earnings yield up 4.0% EBIT / enterprise value
Cheaper than 53% of the market · around average
Revenue growth up 8% year on year
EPS growth down 61% latest quarter · -28 pts
Sales growth down 4% latest quarter · -1 pts
ROE up 6% return on equity
Free cash margin up 6% $105.1M FCF
D/E 0.68 long-term debt / equity
Net debt / EBITDA 3.3×
Interest cover —EBIT / interest
Piotroski tests
  • profitability slipped from last year
  • took on more long-term debt
  • issued more shares
  • profitable on its assets
  • generating cash from operations
  • profits backed by cash
  • short-term liquidity improved
  • gross margin widened
  • assets working harder

Trade setup

ATR% 0.2% $0.22 a day · 2×ATR $126.16
RS 90 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 0.7× vs 50-day average
Up/down volume 0.90 50 sessions
Implied move — no scheduled report
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Shareholders diluted The share count rose 2.4% over the year, from 34m to 34m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported Oct 29, 2026
Results reaction Oct 29, 2026+2% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.9B +8% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.1B FY2021 · $1.2B FY2022 · $1.3B FY2023 · $1.6B FY2024 · $1.7B FY2025 · $1.9B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $102.8M -14% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $77.3M FY2021 · $96.8M FY2022 · $66.4M FY2023 · $90.7M FY2024 · $119.9M FY2025 · $102.8M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $105.1M +5% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $134.5M FY2021 · $103.2M FY2022 · $41.7M FY2023 · $60.3M FY2024 · $99.8M FY2025 · $105.1M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 27%
  • Net 6%
  • Free cash 6%
0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 27% · Net 7% · Free cash 13% FY2021 · Gross 28% · Net 8% · Free cash 8% FY2022 · Gross 26% · Net 5% · Free cash 3% FY2023 · Gross 26% · Net 6% · Free cash 4% FY2024 · Gross 27% · Net 7% · Free cash 6% FY2025 · Gross 27% · Net 6% · Free cash 6%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $1.2B net debt
  • Cash
  • Long-term debt
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $49.2M · Long-term debt $693.8M FY2021 · Cash $17.9M · Long-term debt $812.9M FY2022 · Cash $24.3M · Long-term debt $907.1M FY2023 · Cash $23.7M · Long-term debt $959.9M FY2024 · Cash $46.5M · Long-term debt $980.2M FY2025 · Cash $17.2M · Long-term debt $1.2B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 34.35m +4.4% since FY2020
34.35m 32.91m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 32.91m FY2021 · 33.06m FY2022 · 33.17m FY2023 · 33.33m FY2024 · 33.55m FY2025 · 34.35m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.1B $1.2B $1.3B $1.6B $1.7B $1.9B
Gross margin 27% 28% 26% 26% 27% 27%
Operating income $120.6M $135.7M $112.7M $163.3M $208.2M $221.3M
Net income $77.3M $96.8M $66.4M $90.7M $119.9M $102.8M
Net margin 7% 8% 5% 6% 7% 6%
Earnings per share $2.33 $2.91 $1.99 $2.69 $3.36 $2.89
Free cash flow $134.5M $103.2M $41.7M $60.3M $99.8M $105.1M
Free cash margin 13% 8% 3% 4% 6% 6%
Cash $49.2M $17.9M $24.3M $23.7M $46.5M $17.2M
Long-term debt $693.8M $812.9M $907.1M $959.9M $980.2M $1.2B
Shareholders' equity $1.3B $1.4B $1.4B $1.5B $1.6B $1.7B
Shares outstanding 32.91m 33.06m 33.17m 33.33m 33.55m 34.35m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 29, 2026 Quarterly ↗ Oct 2, 2026 27d
Aug 4, 2026 Quarterly ↗ Jul 3, 2026 32d
Apr 30, 2026 Quarterly ↗ Apr 3, 2026 27d
Feb 23, 2026 Annual ↗ Dec 31, 2025 54d
Oct 23, 2025 Quarterly ↗ Sep 26, 2025 27d
Jul 24, 2025 Quarterly ↗ Jun 27, 2025 27d
Apr 24, 2025 Quarterly ↗ Mar 28, 2025 27d
Feb 20, 2025 Annual ↗ Dec 31, 2024 51d
Oct 24, 2024 Quarterly ↗ Sep 27, 2024 27d
Jul 25, 2024 Quarterly ↗ Jun 28, 2024 27d
Apr 25, 2024 Quarterly ↗ Mar 29, 2024 27d
Feb 20, 2024 Annual ↗ Dec 31, 2023 51d

Current reports